184 related articles for article (PubMed ID: 21248170)
1. Leucovorin-induced hypersensitivity reaction.
Damaske A; Ma N; Williams R
J Oncol Pharm Pract; 2012 Mar; 18(1):136-9. PubMed ID: 21248170
[TBL] [Abstract][Full Text] [Related]
2. [Chemotherapy of colonic cancer].
Block S
Soins; 2010 Mar; (743):46. PubMed ID: 20423037
[No Abstract] [Full Text] [Related]
3. [A case of recurrent colon cancer developed thrombosis in superior mesenteric vein after chemotherapy].
Furuyama H; Fuji H; Okumura S; Nishigori T; Kadokawa Y; Kondo M; Machimoto T; Asao Y; Yoshimura T
Gan To Kagaku Ryoho; 2013 May; 40(5):659-61. PubMed ID: 23863595
[TBL] [Abstract][Full Text] [Related]
4. Interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX).
Jung KH; Kil SY; Choi IK; Seo JH; Shin C; Kim YS; Kim JH
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1181-2. PubMed ID: 17044215
[No Abstract] [Full Text] [Related]
5. [A case of encephalopathy that was suspected to be caused by chemotherapy for colon cancer].
Ganno H; Fujiya K; Nakamura M; Takasaki J; Watayoh Y; Amagasa H; Kurokawa T; Ami K; Fukuda A; Nagahama T; Andoh M; Arai K
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2322-4. PubMed ID: 22202369
[TBL] [Abstract][Full Text] [Related]
6. Hypersensitivity reactions to oxaliplatin in two asian patients.
Ng CV
Ann Pharmacother; 2005 Jun; 39(6):1114-8. PubMed ID: 15886290
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of bolus 5-fluorouracil for recurrent or metastatic colorectal cancer treated with FOLFOX+ BevacizumabTherapy].
Yoshida Y; Hasegawa J; Nishimura J; Hirota M; Kim Y; Nezu R
Gan To Kagaku Ryoho; 2011 Aug; 38(8):1293-6. PubMed ID: 21829066
[TBL] [Abstract][Full Text] [Related]
8. Cryptogenic organizing pneumonia during adjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX) for colon cancer.
Shogbon AO; Hap J; Dretler R; Dalvi AG
J Pharm Pract; 2013 Feb; 26(1):62-6. PubMed ID: 22842502
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic significance of a D-dimer cut-off level of >3 µg/ml in colorectal cancer patients treated with standard chemotherapy plus bevacizumab.
Mochizuki S; Yoshino T; Kojima T; Fuse N; Ikematsu H; Minashi K; Yano T; Tahara M; Kaneko K; Doi T; Koike K; Ohtsu A
Jpn J Clin Oncol; 2010 Oct; 40(10):933-7. PubMed ID: 20494948
[TBL] [Abstract][Full Text] [Related]
10. Acute pain associated with oxaliplatin infusion: case report and literature review.
Clay TD; Ashley DA
J Oncol Pharm Pract; 2012 Dec; 18(4):421-4. PubMed ID: 22080592
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin-related acute disseminated intravascular coagulation syndrome in a patient with metastatic colon cancer.
Malkhasyan K; Halene S; Lacy J
Clin Colorectal Cancer; 2015 Mar; 14(1):e9-e12. PubMed ID: 25446051
[No Abstract] [Full Text] [Related]
12. [Severe gastric and duodenal ulcer after chemotherapy of mFOLFOX6 and bevacizumab].
Fukuhara K; Terakura M; Katsuragi K
Gan To Kagaku Ryoho; 2011 Mar; 38(3):457-9. PubMed ID: 21403454
[TBL] [Abstract][Full Text] [Related]
13. Modified FOLFOX-4 as first-line and salvage treatment in advanced gastric cancer.
Baek YH; Choi SR; Jang JS; Roh MH; Lee JH; Won JJ; Lee CM
Hepatogastroenterology; 2011; 58(105):251-6. PubMed ID: 21510324
[TBL] [Abstract][Full Text] [Related]
14. Late anastomotic dehiscence during bevacizumab therapy for patients with colorectal cancer.
Garant A; Des Groseilliers S; Martin L; Ferland É; Vuong T
Clin Oncol (R Coll Radiol); 2011 Sep; 23(7):497-8. PubMed ID: 21576010
[No Abstract] [Full Text] [Related]
15. [A case of interstitial lung diseases in patient treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX)].
Nakagawa M; Hamada A; Yoshihara Y; Ishizaka T; Fukushima M; Takahashi N; Sawada R; Mukai J
Gan To Kagaku Ryoho; 2011 Feb; 38(2):317-20. PubMed ID: 21368504
[TBL] [Abstract][Full Text] [Related]
16. Hypersensitivity reaction caused by folinic acid administration: a case report and literature review.
Florit-Sureda M; Conde-Estévez D; Vidal J; Montagut C
J Chemother; 2016 Dec; 28(6):500-505. PubMed ID: 26042586
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4) as salvage chemotherapy in patients with pretreated colorectal cancer.
Shitara K; Munakata M; Muto O; Kasai M; Okada R; Mitobe S; Sakata Y
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1079-84. PubMed ID: 17637544
[TBL] [Abstract][Full Text] [Related]
18. [FOLFOX-related hypersensitivity reactions: clinical presentation and management].
Yanai T; Iwasa S; Yamada Y
Nihon Rinsho; 2011 Apr; 69 Suppl 3():541-4. PubMed ID: 22214019
[No Abstract] [Full Text] [Related]
19. Is oxaliplatin combined with weekly bolus 5-fluorouracil and leucovorin an option for stage II and III colon cancer?
Twelves C
Nat Clin Pract Oncol; 2008 Feb; 5(2):72-3. PubMed ID: 18030299
[No Abstract] [Full Text] [Related]
20. Small-cell cancers, and an unusual reaction to chemotherapy: Case 4. Fluorouracil-related small bowel vasculitis.
Bucaloiu ID; Dubagunta S; Pachipala KK; Kamal N; Fata F
J Clin Oncol; 2003 Jun; 21(12):2442-3. PubMed ID: 12805347
[No Abstract] [Full Text] [Related]
[Next] [New Search]
